Haemonetics Corporation

Healthcare · Medical Devices

108.40$ +0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Haemonetics Corporation (HAE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 339 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HAE
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	318	336	343	336	346	349	331	321	327	339	346	339	1,352
Cost of Revenue	148	151	154	157	154	149	149	130	144	148	148	137	576
Gross Profit	171	185	189	179	191	200	182	192	183	191	198	203	776
Research & Development	13	13	24	14	14	16	16	16	15	14	14	16	59
Selling, General & Administrative	105	112	108	108	107	106	115	111	102	107	121	119	448
Total Operating Expenses	135	139	159	140	140	141	130	138	116	122	147	145	530
Operating Income	35	46	30	40	52	59	51	54	67	70	51	57	246
Interest Expense	2.5	1.9	6.5	7.0	7.0	9.1	0.6	4.1	7.2	8.1	5.4	9.9	31
Pre-Tax Income	33	44	23	47	45	50	71	45	51	60	-28	48	130
Income Tax Expense	7.9	13	3.0	8.3	11	12	13	11	13	15	-8.3	15	34
Net Income	25	31	20	38	34	37	58	34	39	45	-20	33	96
EBITDA	66	83	68	80	89	95	99	94	87	95	4.3	75	261

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings